Skip to main content
The BMJ logoLink to The BMJ
. 1992 Jan 18;304(6820):135–136. doi: 10.1136/bmj.304.6820.135

Drug treatment for acute upper gastrointestinal bleeding.

C Brown, W D Rees
PMCID: PMC1881181  PMID: 1737156

Full text

PDF
135

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barer D., Ogilvie A., Henry D., Dronfield M., Coggon D., French S., Ellis S., Atkinson M., Langman M. Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. N Engl J Med. 1983 Jun 30;308(26):1571–1575. doi: 10.1056/NEJM198306303082606. [DOI] [PubMed] [Google Scholar]
  2. Burroughs A. K., McCormick P. A., Hughes M. D., Sprengers D., D'Heygere F., McIntyre N. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology. 1990 Nov;99(5):1388–1395. doi: 10.1016/0016-5085(90)91166-4. [DOI] [PubMed] [Google Scholar]
  3. Christiansen J., Ottenjann R., Von Arx F. Placebo-controlled trial with the somatostatin analogue SMS 201-995 in peptic ulcer bleeding. Gastroenterology. 1989 Sep;97(3):568–574. doi: 10.1016/0016-5085(89)90626-4. [DOI] [PubMed] [Google Scholar]
  4. Collins R., Langman M. Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials. N Engl J Med. 1985 Sep 12;313(11):660–666. doi: 10.1056/NEJM198509123131104. [DOI] [PubMed] [Google Scholar]
  5. Daneshmend T. K., Hawkey C. J., Langman M. J., Logan R. F., Long R. G., Walt R. P. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ. 1992 Jan 18;304(6820):143–147. doi: 10.1136/bmj.304.6820.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Driks M. R., Craven D. E., Celli B. R., Manning M., Burke R. A., Garvin G. M., Kunches L. M., Farber H. W., Wedel S. A., McCabe W. R. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med. 1987 Nov 26;317(22):1376–1382. doi: 10.1056/NEJM198711263172204. [DOI] [PubMed] [Google Scholar]
  7. Hayes P. C., Davis J. M., Lewis J. A., Bouchier I. A. Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet. 1990 Jul 21;336(8708):153–156. doi: 10.1016/0140-6736(90)91668-z. [DOI] [PubMed] [Google Scholar]
  8. Henry D. A., O'Connell D. L. Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. BMJ. 1989 Apr 29;298(6681):1142–1146. doi: 10.1136/bmj.298.6681.1142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Holman R. A., Davis M., Gough K. R., Gartell P., Britton D. C., Smith R. B. Value of a centralised approach in the management of haematemesis and melaena: experience in a district general hospital. Gut. 1990 May;31(5):504–508. doi: 10.1136/gut.31.5.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pérez-Ayuso R. M., Piqué J. M., Bosch J., Panés J., González A., Pérez R., Rigau J., Quintero E., Valderrama R., Viver J. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet. 1991 Jun 15;337(8755):1431–1434. doi: 10.1016/0140-6736(91)93125-s. [DOI] [PubMed] [Google Scholar]
  11. Resnick R. H. Somatostatin for variceal bleeders. Gastroenterology. 1990 Nov;99(5):1524–1526. doi: 10.1016/0016-5085(90)91189-d. [DOI] [PubMed] [Google Scholar]
  12. Somerville K. W., Henry D. A., Davies J. G., Hine K. R., Hawkey C. J., Langman M. J. Somatostatin in treatment of haematemesis and melaena. Lancet. 1985 Jan 19;1(8421):130–132. doi: 10.1016/s0140-6736(85)91903-8. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES